Bispecific antibodies recognize two distinct targets (antigens) expressed on cells, enhancing the activity for cancer immunotherapy. There may be different applications, such as targeting different antigens on a single tumor cell or binding to both a cancer cell and a T cell, bringing them in closer contact to each other.  The aim is to increase the antitumor activity and reduce the chances of developing resistance.